{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T23:12:48Z","timestamp":1785798768451,"version":"3.56.0"},"reference-count":56,"publisher":"MDPI AG","issue":"7","license":[{"start":{"date-parts":[[2022,4,5]],"date-time":"2022-04-05T00:00:00Z","timestamp":1649116800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004166","name":"Medical University of Warsaw","doi-asserted-by":"publisher","award":["2M6\/PM1\/18"],"award-info":[{"award-number":["2M6\/PM1\/18"]}],"id":[{"id":"10.13039\/501100004166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJERPH"],"abstract":"<jats:p>Galectin-3 as a cardiac biomarker has proven to be a significant prognostic tool in adults. However, it has not yet been established in the pediatric population as a biomarker in daily clinical practice. The aim of the study was to summarize the current knowledge on galectin-3 as a biomarker in children with cardiac conditions by reviewing the literature. Bibliographic databases such as PubMed, Web of Science and Embase were searched, and consequently twelve articles met the inclusion criteria. Supplemental handsearching of references delivered one additional source. These prospective studies concerning galectin-3 as a cardiac biomarker present analyses performed in cohorts composed of healthy children and children with cardiovascular diseases. The results, despite being based on small cohort studies, inform that galectin-3 could serve as a potential biomarker in cardiovascular risk stratification in children with heart failure, arrhythmia, Kawasaki disease or in patients undergoing cardiac surgery. The evidence for the usefulness of galectin-3 in the assessment of such pathologies as idiopathic dilated cardiomyopathy, coarctation of the aorta, functionally univentricular heart or tetralogy of Fallot were not completely confirmed. Galectin-3 seems to be a promising biomarker; however, there is a need for further research to establish its use in daily clinical practice.<\/jats:p>","DOI":"10.3390\/ijerph19074349","type":"journal-article","created":{"date-parts":[[2022,4,5]],"date-time":"2022-04-05T06:01:34Z","timestamp":1649138494000},"page":"4349","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["A Scoping Review of Galectin-3 as a Biomarker of Cardiovascular Diseases in Pediatric Populations"],"prefix":"10.3390","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9290-9195","authenticated-orcid":false,"given":"Ewa","family":"Smereczy\u0144ska-Wierzbicka","sequence":"first","affiliation":[{"name":"Department of Pediatric Cardiology and General Pediatrics, Medical University of Warsaw, 02-091 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3810-2822","authenticated-orcid":false,"given":"Rados\u0142aw","family":"Pietrzak","sequence":"additional","affiliation":[{"name":"Department of Pediatric Cardiology and General Pediatrics, Medical University of Warsaw, 02-091 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6416-4106","authenticated-orcid":false,"given":"Bo\u017cena","family":"Werner","sequence":"additional","affiliation":[{"name":"Department of Pediatric Cardiology and General Pediatrics, Medical University of Warsaw, 02-091 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,4,5]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.exer.2010.11.009","article-title":"Focus on Molecules: Galectin-3","volume":"92","author":"Panjwani","year":"2011","journal-title":"Exp. Eye Res."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1007\/s003359900548","article-title":"Mapping of the galectin-3 gene (LGALS3) to human Chromosome 14 at region 14q21-22","volume":"8","author":"Raimond","year":"1997","journal-title":"Mamm. Genome"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.bbagen.2004.03.013","article-title":"Nucleocytoplasmic lectins","volume":"1673","author":"Wang","year":"2004","journal-title":"Biochim. Biophys. Acta (BBA) Gen. Subj."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1083\/jcb.102.2.477","article-title":"Endogenous lectins from cultured cells: Subcellular localization of carbohydrate-binding protein 35 in 3T3 fibroblasts","volume":"102","author":"Moutsatsos","year":"1986","journal-title":"J. Cell Biol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"6452","DOI":"10.1073\/pnas.84.18.6452","article-title":"Endogenous lectins from cultured cells: Nuclear localization of carbohydrate-binding protein 35 in proliferating 3T3 fibroblasts","volume":"84","author":"Moutsatsos","year":"1987","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1007\/BF00731282","article-title":"Expression of galectins on microvessel endothelial cells and their involvement in tumour cell adhesion","volume":"11","author":"Lotan","year":"1994","journal-title":"Glycoconj. J."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.bbagen.2005.12.020","article-title":"Galectin-3: An open-ended story","volume":"1760","author":"Dumic","year":"2006","journal-title":"Biochim. Biophys. Acta (BBA) Gen. Subj."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.12659\/MSM.894035","article-title":"Serum Galectin-3 Levels in Children with Chronic Hepatitis B Infection and Inactive Hepatitis B Carriers","volume":"21","author":"Uluca","year":"2015","journal-title":"Med. Sci. Monit."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/s00381-010-1262-3","article-title":"Galectin-3 expression: A useful tool in the differential diagnosis of posterior fossa tumors in children","volume":"27","author":"Borges","year":"2011","journal-title":"Child\u2019s Nerv. Syst."},{"key":"ref_10","first-page":"315","article-title":"Expression of galectin-3 in nephrotic syndrome glomerulopaties in children","volume":"47","author":"Nowicki","year":"2009","journal-title":"Folia Histochem. Cytobiol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.gene.2014.04.066","article-title":"Expression and clinical significance of galectin-3 in osteosarcoma","volume":"546","author":"Zhou","year":"2014","journal-title":"Gene"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1111\/j.1756-185X.2011.01632.x","article-title":"Elevated production of galectin-3 is correlated with juvenile idiopathic arthritis disease activity, severity, and progression","volume":"14","author":"Ezzat","year":"2011","journal-title":"Int. J. Rheum. Dis."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Mendonca Belmont, T.F., do, O.K., Soares da Silva, A., de Melo Vilar, K., Silva Medeiros, F., Silva Vasconcelos, L.R., dos Anjos, A.C.M., Domingues Hatzlhofer, B.L., da Rocha Pitta, M.G., and Cavalcanti Bezerra, M.A. (2016). Single Nucleotide Polymorphisms at +191 and +292 of Galectin-3 Gene (LGALS3) Related to Lower GAL-3 Serum Levels Are Associated with Frequent Respiratory Tract Infection and Vaso-Occlusive Crisis in Children with Sickle Cell Anemia. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0162297"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1007\/s00431-018-3231-x","article-title":"Subclinical myocardial injury during vaso-occlusive crisis in pediatric sickle cell disease","volume":"177","author":"Wagdy","year":"2018","journal-title":"Eur. J. Pediatr."},{"key":"ref_15","first-page":"53","article-title":"Utility of B-type natriuretic peptide in pediatric cardiology and in children without cardiovascular diseases","volume":"2","author":"Skiendzielewski","year":"2016","journal-title":"Nowa Pediatr."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.cca.2016.04.029","article-title":"Plasma cardiac troponin I concentrations in healthy neonates, children and adolescents measured with a high sensitive immunoassay method: High sensitive troponin I in pediatric age","volume":"458","author":"Caselli","year":"2016","journal-title":"Clin. Chim. Acta"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1016\/j.clinbiochem.2015.08.007","article-title":"Soluble ST2 and galectin-3 in pediatric patients without heart failure","volume":"48","author":"Meeusen","year":"2015","journal-title":"Clin. Biochem."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"357","DOI":"10.2217\/bmm-2015-0044","article-title":"Distribution of circulating cardiac biomarkers in healthy children: From birth through adulthood","volume":"10","author":"Caselli","year":"2016","journal-title":"Biomarkers Med."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s00246-016-1488-2","article-title":"Galectin-3 in Children with Chronic Heart Failure with Normal and Reduced Ejection Fraction: Relationship to Disease Severity","volume":"38","author":"Kotby","year":"2017","journal-title":"Pediatr. Cardiol."},{"key":"ref_20","first-page":"90","article-title":"Mohammed, H.S.G.; Hussien Neama, R. Galectin-3 as Early Detector of Heart Failure in Children with Congenital Acyanotic Heart Disease","volume":"4","author":"Layla","year":"2014","journal-title":"Clin. Med. Diagn."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Saleh, N., Khattab, A., Rizk, M., Salem, S., and Abo-Haded, H. (2020). Value of Galectin-3 assay in children with heart failure secondary to congenital heart diseases: A prospective study. BMC Pediatr., 20.","DOI":"10.1186\/s12887-020-02427-9"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.21608\/ejhm.2020.106017","article-title":"Galectin-3 as a biomarker of heart failure in children with congenital heart disease","volume":"80","author":"Elhewala","year":"2020","journal-title":"Egypt. J. Hosp. Med."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.cardfail.2016.11.006","article-title":"Fibrosis and Fibrotic Gene Expression in Pediatric and Adult Patients With Idiopathic Dilated Cardiomyopathy","volume":"23","author":"Woulfe","year":"2017","journal-title":"J. Card. Fail."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.ijcard.2015.07.063","article-title":"Galectin-3 is a marker of myocardial and vascular fibrosis in Kawasaki disease patients with giant aneurysms","volume":"201","author":"Numano","year":"2015","journal-title":"Int. J. Cardiol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.athoracsur.2019.05.070","article-title":"Novel Biomarkers Improve Prediction of 365-Day Readmission After Pediatric Congenital Heart Surgery","volume":"109","author":"Parker","year":"2020","journal-title":"Ann. Thorac. Surg."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.athoracsur.2020.03.010","article-title":"Cardiac Biomarkers for Risk Stratification of Acute Kidney Injury after Pediatric Cardiac Surgery","volume":"111","author":"Greenberg","year":"2021","journal-title":"Ann. Thorac. Surg."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1017\/S1047951120000451","article-title":"Post-operative acute kidney injury is associated with a biomarker of acute brain injury after paediatric cardiac surgery","volume":"30","author":"Parsons","year":"2020","journal-title":"Cardiol. Young"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1111\/chd.12744","article-title":"Circulating biomarkers of left ventricular hypertrophy in pediatric coarctation of the aorta","volume":"14","author":"Frank","year":"2019","journal-title":"Congenit. Hear. Dis."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1017\/S1047951119002737","article-title":"Heart failure biomarker levels correlate with invasive haemodynamics in pulmonary valve replacement","volume":"30","author":"Zegelbone","year":"2020","journal-title":"Cardiol. Young"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"e015022","DOI":"10.1161\/JAHA.119.015022","article-title":"Associations Between Blood Biomarkers, Cardiac Function, and Adverse Outcome in a Young Fontan Cohort","volume":"10","author":"Bossers","year":"2021","journal-title":"J. Am. Heart Assoc."},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Pietrzak, R., Ksi\u0105\u017cczyk, T., G\u00f3rska, E., Ma\u0142ek, L.A., and Werner, B. (2021). Evaluation of Galectin-3 Plasma Concentration in Adolescents with Ventricular Arrhythmia. Int. J. Environ. Res. Public Health, 18.","DOI":"10.3390\/ijerph18052410"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1161\/HYPERTENSIONAHA.119.12956","article-title":"Characterization of Myocardial Microstructure and Function in an Experimental Model of Isolated Subendocardial Damage","volume":"74","author":"Beyhoff","year":"2019","journal-title":"Hypertension"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.ijcard.2013.08.081","article-title":"Predictive value of serum galectin-3 levels in patients with acute heart failure with preserved ejection fraction","volume":"169","year":"2013","journal-title":"Int. J. Cardiol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/j.ahj.2014.02.011","article-title":"Elevated plasma galectin-3 is associated with near-term rehospitalization in heart failure: A pooled analysis of 3 clinical trials","volume":"167","author":"Meijers","year":"2014","journal-title":"Am. Heart J."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s12967-021-02735-3","article-title":"Biomarker profiling for risk of future heart failure (HFpEF) development","volume":"19","author":"Watson","year":"2021","journal-title":"J. Transl. Med."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1177\/2047487314552797","article-title":"Utility of galectin-3 as a prognostic biomarker in heart failure: Where do we stand?","volume":"22","author":"Srivatsan","year":"2015","journal-title":"Eur. J. Prev. Cardiol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.jacc.2017.04.025","article-title":"2017 ACC\/AHA\/HFSA Focused Update of the 2013 ACCF\/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America","volume":"70","author":"Yancy","year":"2017","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1093\/eurheartj\/ehw128","article-title":"2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC","volume":"37","author":"Ponikowski","year":"2016","journal-title":"Eur. Heart J."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1111\/jch.12757","article-title":"Galectin-3 Predicts Left Ventricular Remodeling of Hypertension","volume":"18","author":"Yao","year":"2016","journal-title":"J. Clin. Hypertens."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"2958219","DOI":"10.1155\/2018\/2958219","article-title":"Galectin-3 as a Predictor of Left Ventricular Reverse Remodeling in Recent-Onset Dilated Cardiomyopathy","volume":"2018","author":"Karatolios","year":"2018","journal-title":"Dis. Markers"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"e002706","DOI":"10.1161\/JAHA.115.002706","article-title":"Galectin-3 Is Elevated and Associated With Adverse Outcomes in Patients With Single-Ventricle Fontan Circulation","volume":"5","author":"Opotowsky","year":"2016","journal-title":"J. Am. Heart Assoc."},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Frogoudaki, A.A., Pantelakis, I., Bistola, V., Kroupis, C., Birba, D., Ikonomidis, I., Alexopoulos, D., Filippatos, G., and Parissis, J. (2020). Global Longitudinal Strain of the Systemic Ventricle Is Correlated with Plasma Galectin-3 and Predicts Major Cardiovascular Events in Adult Patients with Congenital Heart Disease. Medicina, 56.","DOI":"10.3390\/medicina56060305"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"e013745","DOI":"10.1161\/JAHA.119.013745","article-title":"Exploring the Prognostic Value of Novel Markers in Adults With a Systemic Right Ventricle","volume":"8","author":"Geenen","year":"2019","journal-title":"J. Am. Heart Assoc."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1080\/00015385.2017.1335371","article-title":"Galectin-3 correlates with arrhythmogenic right ventricular cardiomyopathy and predicts the risk of ventricular  arrhythmias in patients with implantable defibrillators","volume":"72","author":"Oz","year":"2017","journal-title":"Acta Cardiol."},{"key":"ref_45","first-page":"100582","article-title":"Evolution of blood biomarker levels following percutaneous atrial septal defect closure in adults","volume":"30","author":"Geenen","year":"2020","journal-title":"Int. J. Cardiol. Heart Vasc."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.2217\/bmm-2020-0250","article-title":"Galectin-3 plasma levels in adult congenital heart disease and the pressure overloaded right ventricle: Reason matters","volume":"14","author":"Kowalik","year":"2020","journal-title":"Biomark. Med."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1007\/s00380-015-0691-z","article-title":"Galectin-3 levels are associated with right ventricular functional and morphologic changes in pulmonary arterial hypertension","volume":"31","author":"Fenster","year":"2016","journal-title":"Heart Vessel."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"ii36","DOI":"10.1136\/heartjnl-2014-307238","article-title":"Genetic testing and blood biomarkers in paediatric pulmonary hypertension. Expert consensus statement on the diagnosis and treatment of paediatric pulmonary hypertension. The European Paediatric Pulmonary Vascular Disease Network, endorsed by ISHLT and DGPK","volume":"102","author":"Pattathu","year":"2016","journal-title":"Heart"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.jacbts.2016.03.003","article-title":"Galectin-3 Regulates Atrial Fibrillation Remodeling and Predicts Catheter Ablation Outcomes","volume":"1","author":"Takemoto","year":"2016","journal-title":"JACC Basic Transl. Sci."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.amjcard.2014.12.021","article-title":"Effects of Persistent Atrial Fibrillation on Serum Galectin-3 Levels","volume":"115","author":"Gurses","year":"2015","journal-title":"Am. J. Cardiol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"e0123574","DOI":"10.1371\/journal.pone.0123574","article-title":"Galectin-3 in Patients with Atrial Fibrillation Undergoing Radiofrequency Catheter Ablation","volume":"10","author":"Kornej","year":"2015","journal-title":"PLoS ONE"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1093\/europace\/euv045","article-title":"Plasma galectin-3 predicts clinical outcomes after catheter ablation in persistent atrial fibrillation patients without structural heart disease","volume":"17","author":"Wu","year":"2015","journal-title":"Europace"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"34357","DOI":"10.1038\/srep34357","article-title":"Serum Galectin-3 Levels Predict Recurrences after Ablation of Atrial Fibrillation","volume":"6","author":"Clementy","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1093\/europace\/eux090","article-title":"The change in circulating galectin-3 predicts absence of atrial fibrillation after thoracoscopic surgical ablation","volume":"20","author":"Berger","year":"2017","journal-title":"Europace"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.repc.2020.12.013","article-title":"A new biomarker that predicts ventricular arrhythmia in patients with ischemic dilated cardiomyopathy: Galectin-3","volume":"40","author":"Erdogan","year":"2021","journal-title":"Rev. Port. Cardiol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/s00431-017-3079-5","article-title":"Galectin-3 levels relate in children to total body fat, abdominal fat, body fat distribution, and cardiac size","volume":"177","author":"Dencker","year":"2018","journal-title":"Eur. J. Pediatr."}],"container-title":["International Journal of Environmental Research and Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1660-4601\/19\/7\/4349\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T22:49:53Z","timestamp":1760136593000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1660-4601\/19\/7\/4349"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,5]]},"references-count":56,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2022,4]]}},"alternative-id":["ijerph19074349"],"URL":"https:\/\/doi.org\/10.3390\/ijerph19074349","relation":{},"ISSN":["1660-4601"],"issn-type":[{"value":"1660-4601","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,5]]}}}